The Agilent 400-DS Dissolution Apparatus 7 sets the performance standard for small-volume drug-release testing of medical devices such as drug eluting stents (DES). A variety of standard and custom holders are available for testing of combinatorial products, pacemaker leads, contact lenses, catheters, wound care products, extractables, leachables and more.
It is the first dissolution apparatus built specifically for small-volume dissolution testing of combination drug products that meets all compendial requirements for USP Apparatus 7. The 400-DS complies with 21 CFR Part 11 guidelines and brings an unprecedented level of convenience, throughput, and efficiency to your quality control and R&D operations.
Take a look at our 400-DS webinar recording
for more information on this small-volume testing product.